Product Information
DYANAVEL XR 5 MG TABLET is a brand product labeled by NextWave Pharmaceuticals, Inc, priced at $7.8501 per EA under NDC 24478010601. Its NADAC has been published 149 times since Oct 18, 2023.
FDA first approved this application on Nov 4, 2021.
Strength
5 mg/1
Manufacturer
NextWave Pharmaceuticals, IncNDC
24478010601
Classification
Brand
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
AMPHETAMINEApproval Type
New Drug (NDA)
FDA Application
NDA210526FDA Approved
11/4/2021
On Market Since
11/4/2021
Pharmacological Classes
Price Statistics
The NADAC for DYANAVEL XR 5 MG TABLET has been published 149 times since Oct 18, 2023, and over the history we have for it it has risen 9.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $7.8501 per EA |
|---|---|
| All-time high | $7.8553 (Jun 10, 2026) |
| All-time low | $7.1616 (Oct 18, 2023) |
| 52-week high | $7.8553 |
| 52-week low | $7.6840 |
| Median price | $7.5534 |
| Average price | $7.6176 |
| Largest weekly change | +4.9% (Jan 17, 2024) |
| Weeks tracked | 149 |
| Tracking since | Oct 18, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the amphetamine market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DYANAVEL XR 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for DYANAVEL XR 5 MG TABLET, manufactured by NextWave Pharmaceuticals, Inc, is $7.8501 per EA (NDC 24478010601), effective Aug 19, 2026.
How has the price of DYANAVEL XR 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for DYANAVEL XR 5 MG TABLET has risen 9.6%. It has been tracked across 149 weekly CMS publications since Oct 18, 2023.
What are the highest and lowest recorded NADAC prices for DYANAVEL XR 5 MG TABLET?
Since Oct 18, 2023, the NADAC for DYANAVEL XR 5 MG TABLET has ranged from a low of $7.1616 (Oct 18, 2023) to a high of $7.8553 (Jun 10, 2026), with a median of $7.5534 per EA.
Are there cheaper alternatives to DYANAVEL XR 5 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of DYANAVEL XR 5 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures DYANAVEL XR 5 MG TABLET?
DYANAVEL XR 5 MG TABLET (NDC 24478010601) is labeled by NextWave Pharmaceuticals, Inc, and CMS classifies it as a brand product.